The Arrhythmic Phenotype in Cardiomyopathy - 11/11/21
, Giulia Grilli, MD a, 1, Chiara Cappelletto, MD a, Marco Masé, MD a, Aldostefano Porcari, MD a, Matteo Dal Ferro, MD a, Marta Gigli, MD a, Davide Stolfo, MD a, Massimo Zecchin, MD a, Antonio De Luca, MD a, Luisa Mestroni, MD, FACC, FAHA, FESC b, Gianfranco Sinagra, MD, FESC aRésumé |
In the wide phenotypic spectrum of cardiomyopathies, sudden cardiac death (SCD) has always been the most visible and devastating disease complication. The introduction of implantable cardioverter-defibrillators for SCD prevention by the late 1980s has moved the question from how to whom we should protect from SCD, leaving clinicians with a measure of uncertainty regarding the most reliable option to guide identification of the highest-risk patients. In this review, we will go through all the available evidence in the field of arrhythmic expression and arrhythmic risk stratification in the different phenotypes of cardiomyopathies to provide practical suggestions in daily clinical management.
Le texte complet de cet article est disponible en PDF.Keywords : Cardiomyopathies, Sudden cardiac death, Arrhythmic risk stratification
Plan
Vol 18 - N° 1
P. 101-113 - janvier 2022 Retour au numéro
Article précédent
- Clinical and Molecular Aspects of Naxos Disease
- Ioannis Protonotarios, Angeliki Asimaki, Zafeirenia Xylouri, Alexandros Protonotarios, Adalena Tsatsopoulou
- The Risk of Sudden Unexpected Cardiac Death in Children : Epidemiology, Clinical Causes, and Prevention
- Emanuele Monda, Michele Lioncino, Marta Rubino, Martina Caiazza, Annapaola Cirillo, Adelaide Fusco, Roberta Pacileo, Fabio Fimiani, Federica Amodio, Nunzia Borrelli, Diego Colonna, Barbara D’Onofrio, Giulia Frisso, Fabrizio Drago, Silvia Castelletti, Berardo Sarubbi, Paolo Calabrò, Maria Giovanna Russo, Giuseppe Limongelli
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?